X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs LUPIN LTD - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. LUPIN LTD WOCKHARDT LTD./
LUPIN LTD
 
P/E (TTM) x 17.1 16.8 101.9% View Chart
P/BV x 1.7 3.9 44.6% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 WOCKHARDT LTD.   LUPIN LTD
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-16
LUPIN LTD
Mar-16
WOCKHARDT LTD./
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs2,0002,127 94.0%   
Low Rs7061,294 54.5%   
Sales per share (Unadj.) Rs403.7304.1 132.8%  
Earnings per share (Unadj.) Rs29.550.4 58.5%  
Cash flow per share (Unadj.) Rs42.460.7 69.8%  
Dividends per share (Unadj.) Rs07.50 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs323.4243.8 132.7%  
Shares outstanding (eoy) m110.51450.58 24.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.45.6 59.6%   
Avg P/E ratio x45.933.9 135.3%  
P/CF ratio (eoy) x31.928.2 113.3%  
Price / Book Value ratio x4.27.0 59.6%  
Dividend payout %014.9 0.0%   
Avg Mkt Cap Rs m149,509770,740 19.4%   
No. of employees `0007.416.4 45.1%   
Total wages/salary Rs m9,44321,077 44.8%   
Avg. sales/employee Rs Th6,048.68,379.6 72.2%   
Avg. wages/employee Rs Th1,280.21,289.0 99.3%   
Avg. net profit/employee Rs Th441.51,388.7 31.8%   
INCOME DATA
Net Sales Rs m44,614137,016 32.6%  
Other income Rs m9701,877 51.7%   
Total revenues Rs m45,584138,893 32.8%   
Gross profit Rs m5,03837,535 13.4%  
Depreciation Rs m1,4264,635 30.8%   
Interest Rs m1,012446 226.8%   
Profit before tax Rs m3,57034,330 10.4%   
Minority Interest Rs m-65-88 74.3%   
Prior Period Items Rs m60-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m25511,536 2.2%   
Profit after tax Rs m3,25722,707 14.3%  
Gross profit margin %11.327.4 41.2%  
Effective tax rate %7.133.6 21.2%   
Net profit margin %7.316.6 44.0%  
BALANCE SHEET DATA
Current assets Rs m39,90697,790 40.8%   
Current liabilities Rs m18,42353,872 34.2%   
Net working cap to sales %48.232.1 150.2%  
Current ratio x2.21.8 119.3%  
Inventory Days Days9085 106.5%  
Debtors Days Days98121 81.0%  
Net fixed assets Rs m35,83286,379 41.5%   
Share capital Rs m553901 61.3%   
"Free" reserves Rs m30,370105,735 28.7%   
Net worth Rs m35,739109,844 32.5%   
Long term debt Rs m16,54253,739 30.8%   
Total assets Rs m79,522224,378 35.4%  
Interest coverage x4.577.9 5.8%   
Debt to equity ratio x0.50.5 94.6%  
Sales to assets ratio x0.60.6 91.9%   
Return on assets %5.410.3 52.0%  
Return on equity %9.120.7 44.1%  
Return on capital %8.721.2 40.8%  
Exports to sales %11.649.1 23.6%   
Imports to sales %4.57.4 59.9%   
Exports (fob) Rs m5,17767,244 7.7%   
Imports (cif) Rs m1,99010,199 19.5%   
Fx inflow Rs m7,58971,405 10.6%   
Fx outflow Rs m2,87817,807 16.2%   
Net fx Rs m4,71153,598 8.8%   
CASH FLOW
From Operations Rs m716-3,690 -19.4%  
From Investments Rs m-8,182-69,434 11.8%  
From Financial Activity Rs m2,54358,126 4.4%  
Net Cashflow Rs m-4,923-14,998 32.8%  

Share Holding

Indian Promoters % 74.5 46.6 159.9%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 2.3 11.3 20.4%  
FIIs % 7.7 31.9 24.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 10.1 152.5%  
Shareholders   67,757 98,259 69.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   ALEMBIC LTD  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  SUN PHARMA  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 17, 2017 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - SHASUN PHARMA COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS